Probe field ellipticity-induced shift in an atomic clock

We investigate the probe field induced shift for atomic lattice-based and ion-trap clocks, which can be considered as a near resonant ac-Stark shift, connected to the Zeeman structure of atomic levels and their splitting in a dc magnetic field. This shift arises from possible residual ellipticity in the polarization of the probe field and uncertainty in the magnetic field orientation. Such a shift can have an arbitrary sign and, for some experimental conditions, can reach the fractional value of the order of 10$^{-18}$-10$^{-19}$, i.e., it is not negligible. Thus, it should be taken into account in the uncertainty budgets for the modern ultra-precise atomic clocks. In addition, it is shown that when using hyper-Ramsey spectroscopy, this shift can be reduced to a level much lower than $10^{-19}$.Comment: 8 pages, 6 figure

Report from the EPAA workshop: In vitro ADME in safety testing used by EPAA industry sectors

AbstractThere are now numerous in vitro and in silico ADME alternatives to in vivo assays but how do different industries incorporate them into their decision tree approaches for risk assessment, bearing in mind that the chemicals tested are intended for widely varying purposes? The extent of the use of animal tests is mainly driven by regulations or by the lack of a suitable in vitro model. Therefore, what considerations are needed for alternative models and how can they be improved so that they can be used as part of the risk assessment process? To address these issues, the European Partnership for Alternative Approaches to Animal Testing (EPAA) working group on prioritisation, promotion and implementation of the 3Rs research held a workshop in November, 2008 in Duesseldorf, Germany. Participants included different industry sectors such as pharmaceuticals, cosmetics, industrial- and agro-chemicals. This report describes the outcome of the discussions and recommendations (a) to reduce the number of animals used for determining the ADME properties of chemicals and (b) for considerations and actions regarding in vitro and in silico assays. These included: standardisation and promotion of in vitro assays so that they may become accepted by regulators; increased availability of industry in vivo kinetic data for a central database to increase the power of in silico predictions; expansion of the applicability domains of in vitro and in silico tools (which are not necessarily more applicable or even exclusive to one particular sector) and continued collaborations between regulators, academia and industry. A recommended immediate course of action was to establish an expert panel of users, developers and regulators to define the testing scope of models for different chemical classes. It was agreed by all participants that improvement and harmonization of alternative approaches is needed for all sectors and this will most effectively be achieved by stakeholders from different sectors sharing data

Present state and future perspectives of using pluripotent stem cells in toxicology research

The use of novel drugs and chemicals requires reliable data on their potential toxic effects on humans. Current test systems are mainly based on animals or in vitro–cultured animal-derived cells and do not or not sufficiently mirror the situation in humans. Therefore, in vitro models based on human pluripotent stem cells (hPSCs) have become an attractive alternative. The article summarizes the characteristics of pluripotent stem cells, including embryonic carcinoma and embryonic germ cells, and discusses the potential of pluripotent stem cells for safety pharmacology and toxicology. Special attention is directed to the potential application of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) for the assessment of developmental toxicology as well as cardio- and hepatotoxicology. With respect to embryotoxicology, recent achievements of the embryonic stem cell test (EST) are described and current limitations as well as prospects of embryotoxicity studies using pluripotent stem cells are discussed. Furthermore, recent efforts to establish hPSC-based cell models for testing cardio- and hepatotoxicity are presented. In this context, methods for differentiation and selection of cardiac and hepatic cells from hPSCs are summarized, requirements and implications with respect to the use of these cells in safety pharmacology and toxicology are presented, and future challenges and perspectives of using hPSCs are discussed

Conceptual design of the ATLAS EM muon chamber support structures

The conceptual design of the support structures of the EM muon chambers is presented. On each side of the detector the EM chambers are arranged in four layers: one layer of MDTs and the three layers of TGCs. The chambers are mounted on four individual wheel structures per side. The four wheels are inclined by 1.23% and suspended from two longitudinal beams parallel to the beam axis. In order to allow for the opening of the ATLAS detector the wheels can be displaced longitudinally over a distance of 6 m. In addition individual wheels can be separated from each other by up to 1 m for maintenance purposes

New 4'-functionalized 2,2':6',2''-terpyridines for applications in macromolecular chemistry and nanoscience

The well-known reaction of 4'-chloro-2,2':6',2''-terpyridine with alkoxide nucleophiles leads to 4'-functionalized 2,2':6',2''-terpyridines. This reaction allows the easy introduction of different functional groups onto the terpyridine at the 4'-position, i.e., opposite to the metal binding site, in one reaction step. Among the functionalized 2,2':6',2''-terpyridines reported here are amines (including chiral examples), carboxylic acids, simple alkoxy-chain terpyridines with different chain lengths, and a stilbene-functionalized terpyridine (I). Moreover, the synthesis of two important already known substances was significantly improved. One example of a sequential functionalization of an (aminopentoxy)terpyridine with a dithiolane functionality, yielding II, is also reported. For two of the alkoxy-chain-functionalized terpyridines, single-crystal x-ray crystallog. data were obtained. Finally, ordered monolayers of alkoxy-substituted terpyridines III (n = 11, 17) on highly ordered pyrolytic graphite were visualized using STM. [on SciFinder (R)